Allstate Corporation’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$494K Buy
12,007
+3,775
+46% +$143K ﹤0.01% 1039
2026
Q1
$294K Buy
+8,232
New +$299K ﹤0.01% 1076
2022
Q1
Sell
-13,918
Closed -$1.41M 624
2021
Q4
$1.41M Sell
13,918
-2,555
-16% -$260K 0.03% 467
2021
Q3
$1.6M Sell
16,473
-1,064
-6% -$107K 0.07% 172
2021
Q2
$1.81M Sell
17,537
-3,383
-16% -$345K 0.06% 160
2021
Q1
$1.86M Buy
20,920
+2,904
+16% +$269K 0.06% 170
2020
Q4
$1.7M Buy
18,016
+1,373
+8% +$121K 0.05% 166
2020
Q3
$1.44M Buy
16,643
+5,718
+52% +$476K 0.05% 163
2020
Q2
$882K Buy
10,925
+145
+1% +$11.5K 0.03% 282
2020
Q1
$709K Sell
10,780
-2,330
-18% -$224K 0.03% 286
2019
Q4
$1.43M Buy
+13,110
New +$1.33M 0.03% 370

Other funds holding CRI

Allstate Corporation's CRI Position: Q2 2026 in Review

Allstate Corporation increased its Carter's (CRI) stake by 46% in Q2 2026, buying an estimated $143K and bringing the position to 12,007 shares worth $494K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Allstate Corporation first reported a position in CRI in Q4 2019 and has held it in 11 quarters since. The position peaked at $1.86M in Q1 2021. 287 funds tracked by Wall St. Rank hold CRI as of Q2 2026.

  • Allstate Corporation held 12,007 shares of Carter's worth $494K as of Q2 2026.
  • Allstate Corporation bought 3,775 Carter's shares in Q2 2026, an estimated $143K.
  • Carter's made up ﹤0.01% of Allstate Corporation's portfolio in Q2 2026, its #1039 holding.
  • Allstate Corporation first reported a position in Carter's in Q4 2019 and has held it in 11 quarters since.
  • Allstate Corporation's Carter's position peaked at $1.86M in Q1 2021.
  • 287 funds tracked by Wall St. Rank held Carter's as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.